Mutual funds holding Molbio Diagnostics
Healthcare · Small Cap. From each fund's Aug 2026 portfolio.
Funds holding it
26
26 active, 0 index
Held by these funds
₹659 Cr
approx., weight × fund size
Largest weight, active fund
4.53%
Kotak Healthcare Fund
Every fund holding Molbio Diagnostics
| Fund | Category | Weight in fund | Value held |
|---|---|---|---|
| Sector Specific - Pharma | 4.53% | ₹37.38 Cr | |
| Sector Specific - Pharma | 1.77% | ₹61.97 Cr | |
| Thematic - MNC | 1.51% | ₹8.07 Cr | |
| Sector Specific - Pharma | 1.44% | ₹50.32 Cr | |
| Aggressive Hybrid Fund | 1.40% | ₹127 Cr | |
| Thematic - Service Industries | 1.04% | ₹15.12 Cr | |
| Thematic - Contra | 1.02% | ₹53.00 Cr | |
| Flexi - Cap | 1.02% | ₹44.56 Cr | |
| Sector Specific - Pharma | 0.98% | ₹9.08 Cr | |
| Thematic - Business Cycles | 0.94% | ₹18.82 Cr | |
| Solution Oriented - Retirement | 0.94% | ₹97.49 L | |
| Thematic - Consumption | 0.91% | ₹15.11 Cr | |
| Aggressive Hybrid Fund | 0.90% | ₹5.35 Cr | |
| Sector Specific - Pharma | 0.87% | ₹13.15 Cr | |
| Large & Mid Cap | 0.81% | ₹6.30 Cr | |
| Equity Savings Fund | 0.61% | ₹10.40 Cr | |
| Thematic - Innovation | 0.60% | ₹17.54 Cr | |
| Thematic - IPO | 0.59% | ₹7.53 Cr | |
| Value Fund | 0.44% | ₹35.37 Cr | |
| Sector Specific - Pharma | 0.44% | ₹40.33 Cr | |
| Large Cap | 0.43% | ₹12.58 Cr | |
| Thematic - Innovation | 0.37% | ₹11.66 Cr | |
| Large Cap | 0.30% | ₹31.54 Cr | |
| Small Cap | 0.30% | ₹17.46 Cr | |
| Conservative Hybrid Fund | 0.17% | ₹4.65 Cr | |
| Multi Asset Allocation | 0.03% | ₹4.57 Cr |
Look up another stock
How many mutual funds hold Molbio Diagnostics?
26 mutual funds held Molbio Diagnostics in their Aug 2026 portfolios: 26 actively managed funds and 0 index funds and ETFs.
Which mutual fund has the highest holding in Molbio Diagnostics?
By weight in the fund, the largest actively managed holders are Kotak Healthcare Fund, HDFC Pharma and Healthcare Fund, HDFC MNC Fund.
Where does this data come from?
Each fund's latest monthly portfolio disclosure. Value held is the stock's weight in the fund multiplied by the fund's assets, so it is approximate.
See also portfolio overlap between two funds. Not a recommendation to buy or sell any stock or fund.